Library›Enzyme Chemistry

Enzyme Chemistry

1. Enzyme Chemistry

Enzyme chemistry is the connective tissue of this whole Library. An enzyme is a biological catalyst — almost always a protein — that takes one molecule (the substrate) and turns it into another (the product), fast and selectively, under body-temperature conditions. Every substance in this Library is on one or both sides of some enzyme's reaction: a plant builds a cannabinoid or an alkaloid with enzymes, and your body takes that same molecule apart (or switches it on) with other enzymes. This article teaches both directions at once — the anabolic / biosynthetic lens (how one thing *becomes* another, "this or that") and the metabolic lens (what is actually happening in your body when you take something) — and it maps the specific transformations onto the articles that already cover them in depth. For the quantitative side (Km, Vmax, Ki, competitive vs. non-competitive inhibition, transporters) see Enzyme Inhibition Kinetics and Molecular Transporters.

1. The Two Directions Every Enzyme Serves

• Anabolism / biosynthesis (building up): small, cheap precursors are assembled into complex, valuable molecules — a plant turning fatty-acid and sugar scraps into THCA, or a cell methylating theobromine into caffeine. This is where "a synthesis that could be profitable" actually lives legitimately: give a microbe or a cell the right enzymes and feedstock and it grows the product (see §6, fermentation).
• Catabolism / metabolism (breaking down or switching): the body transforms a molecule to use it, activate it, or clear it — oxidizing caffeine, hydrolyzing acetylcholine, deaminating serotonin. This is where dose, duration, interactions, and danger come from.
• The same molecule is usually a product of one enzyme and a substrate of the next. Health, potency, and toxicity are all questions of which enzyme wins the competition for a given molecule — and that is something you can deliberately steer (§5).

2. The Cofactors That Power the Transformations

Most enzymes cannot act alone; they need a small-molecule cofactor that carries the group being moved. Learn these five and most biochemistry becomes readable:

• SAM (S-adenosylmethionine) — the universal methyl donor. Every "add a methyl group" step runs on SAM: theobromine → caffeine, noradrenaline → adrenaline, the O-methylation of catecholamines by COMT. SAM is regenerated through the folate/methionine cycle — which is why L-Methylfolate and Choline Donors matter to methylation capacity.
• PLP (pyridoxal-5′-phosphate, vitamin B6) — decarboxylation and transamination. Every "remove the carboxyl, make the amine" step: L-DOPA → dopamine, 5-HTP → serotonin, histidine → histamine.
• BH4 (tetrahydrobiopterin) — aromatic hydroxylation. Tyrosine → L-DOPA and tryptophan → 5-HTP both need BH4.
• NAD(P)H and FAD — the redox currency. Oxidations and reductions, including the Cytochrome P450 System Inhibition and Induction monooxygenases (which also use O₂) and the flavin of monoamine oxidase.
• CoA / acyl-CoA and ATP — activation and acyl transfer. Hexanoyl-CoA and malonyl-CoA feed the cannabinoid polyketide; acetyl-CoA + choline makes acetylcholine.

3. The Enzyme Classes, With Library Examples

• Transferases (move a group): methyltransferases (SAM) make caffeine and adrenaline; prenyltransferase builds the cannabinoid skeleton; ChAT transfers acetyl to choline.
• Oxidoreductases (redox): CYP450 (Phase-I oxidation), monoamine oxidase (deaminates serotonin/dopamine — see Monoamine Oxidase Inhibitors and Neurotransmitter Systems), tyrosine/tryptophan hydroxylases, dopamine-β-hydroxylase.
• Hydrolases (add water, cleave): acetylcholinesterase (Cholinergic Neurotransmission and Cholinesterase Inhibition), salivary esterases, and FAAH, which ends the anandamide signal (Endocannabinoid Chemistry and 2-AG Metabolism).
• Lyases / decarboxylases (PLP): aromatic L-amino-acid decarboxylase makes dopamine and serotonin from their precursors.
• Synthases / ligases (assemble): polyketide synthase + olivetolic-acid cyclase and the cannabinoid synthases (THCA/CBDA/CBCA synthase); caffeine synthase.
• Isomerases (rearrange): e.g. the geranyl/neryl-PP isomerase that feeds cannabinoid prenylation.

4. Worked Transformations — How One Thing Becomes Another

Each line is substrate → product (enzyme, cofactor), with the article that covers it in depth.

• Theobromine → caffeine (caffeine synthase / N-methyltransferase, SAM). The whole purine series — xanthosine → 7-methylxanthine → theobromine → caffeine — is one methyltransferase after another. See Caffeine Extraction.
• Hexanoyl-CoA + 3 malonyl-CoA → olivetolic acid → CBGA → THCA / CBDA / CBCA (polyketide synthase + olivetolic-acid cyclase; then prenyltransferase; then the Δ⁹-THCA / CBDA / CBCA synthases). THCA and CBDA then become THC and CBD by non-enzymatic decarboxylation (heat). This is the cannabinoid pathway, and the direct structural cousin of the caffeine purine pathway.
• L-Tyrosine → L-DOPA (tyrosine hydroxylase, BH4) → dopamine (AADC, PLP) → noradrenaline (dopamine-β-hydroxylase) → adrenaline (PNMT, SAM). Velvet bean (Mucuna pruriens) is a direct L-DOPA source that enters this chain. See Catecholamines Transporters and Monoamine Reuptake.
• L-Tryptophan → 5-HTP (tryptophan hydroxylase, BH4) → serotonin (AADC, PLP) → melatonin (N-acetylation + SAM methylation). See Monoamine Oxidase Inhibitors and Neurotransmitter Systems.
• Choline + acetyl-CoA → acetylcholine (choline acetyltransferase); then acetylcholine → choline + acetate (acetylcholinesterase). The whole on/off switch of the cholinergic synapse. See Cholinergic Neurotransmission and Cholinesterase Inhibition and Choline Donors.
• Codeine → morphine (CYP2D6, O-demethylation) — a prodrug bioactivation: the body's enzyme makes the active drug. See Cannabinoid and Tryptamine Prodrugs and Cytochrome P450 System Inhibition and Induction.
• Folate → dihydrofolate → tetrahydrofolate → L-methylfolate, feeding methionine → SAM — the engine that powers every methylation above. See L-Methylfolate.

5. Metabolic Redirection — Utilizing Enzymes to Steer Where a Molecule Goes

Because a molecule is fought over by competing enzymes, you can decide the outcome by three levers — the operational heart of this Library's pharmacology:

• Supply the substrate and cofactor (precursor loading): give the body L-DOPA (mucuna), 5-HTP, choline, or methyl donors (L-Methylfolate) and you push the building pathway toward its product.
• Inhibit the enzyme that would destroy it: this is the huasca phenomenon — an MAO inhibitor lets orally-taken tryptamines survive the gut and liver instead of being deaminated, and black-pepper piperine or grapefruit furanocoumarins inhibit CYP enzymes to raise and lengthen exposure. See Bioavailability Metabolic Inhibition and Synergy, Oilahuasca, Cannabinoid Oilahuasca.
• Induce the enzyme to clear it faster: chronic exposure (e.g. tobacco smoke inducing CYP1A2) speeds clearance, which is why smokers metabolize caffeine faster and why quitting can cause caffeine to pile up.

6. Biosynthesis as the Modern "Profitable Synthesis"

The legitimate, patentable way to make a valuable molecule is often to let an enzyme do it. Give an engineered microbe (yeast or E. coli) the biosynthetic enzymes and cheap feedstock and it ferments the product: caffeine from the methyltransferase pathway (§4), or cannabinoids from the olivetolic-acid pathway — the same diagrams the cannabis plant runs, moved into a fermenter. This is clean, scalable, and lawful where the product is, and it is the honest home of "a synthesis that could be profitable." Chemical total synthesis (see Caffeine Extraction §9) is the alternative when no biological route is available.

7. What Is Happening in Your Body — The Metabolism Lens

When you take any substance, it runs a gauntlet of enzymes, and knowing the gauntlet is knowing the dose and the danger:

• Phase I (functionalization): mostly CYP450 oxidations that add or expose a reactive handle — and that can activate a prodrug (codeine → morphine) or inactivate a drug. First-pass metabolism in gut and liver is why oral doses differ so much from sublingual or inhaled (Sublingual Absorption and Salivary Enzymes).
• Phase II (conjugation): glucuronidation, sulfation, methylation (COMT), acetylation, and glutathione tagging make the molecule water-soluble for excretion.
• The amine-handling enzymes: MAO deaminates serotonin, dopamine, and tyramine; this is why an MAOI plus aged cheese (tyramine) risks a hypertensive crisis, and an MAOI plus a serotonergic risks serotonin syndrome. See Monoamine Oxidase Inhibitors and Neurotransmitter Systems.
• The interaction map is the risk map: most dangerous combinations are enzyme-mediated — a CYP inhibitor stacking a drug to toxic levels, an MAOI removing a safety valve, an induced enzyme causing withdrawal of effect. This is covered quantitatively in Enzyme Inhibition Kinetics and Molecular Transporters and practically in Bioavailability Metabolic Inhibition and Synergy.

8. Safety and Harm Reduction

The enzyme layer is exactly where the serious interactions live, so it is taught as part of the chemistry, not withheld. MAOI + tyramine (aged/fermented foods) → hypertensive crisis. MAOI + serotonergic (SSRIs, tryptamines, some cough suppressants) → serotonin syndrome. CYP inhibition (grapefruit, some antifungals, ritonavir) can multiply blood levels of an ordinary dose into an overdose. Enzyme induction (smoking, St. John's Wort, carbamazepine) can silently drop a drug below effect — including hormonal contraceptives. Before combining anything in this Library, ask the enzyme question first: what processes this, and what else am I giving that speeds it up or shuts it down?

See also

• Enzyme Inhibition Kinetics and Molecular Transporters
• Cytochrome P450 System Inhibition and Induction
• Monoamine Oxidase Inhibitors and Neurotransmitter Systems
• The Huasca Phenomenon and Metabolic Redirection
• Catecholamines Transporters and Monoamine Reuptake
• Cholinergic Neurotransmission and Cholinesterase Inhibition
• Bioavailability Metabolic Inhibition and Synergy
• L-Methylfolate · Choline Donors · Caffeine Extraction · Cannabinoid and Tryptamine Prodrugs · Endocannabinoid Chemistry and 2-AG Metabolism

Filed under  Other